Endoscopic mucosal resection for colonic diffic ult sessile polyps and early superficial colonic tumo urs , an alternative effective method to colonic surgery . A Middle Eastern co untry experience

No abstrac

AN INVESTIGATION OF A MICRO-SCALE RANQUE-HILSCH VORTEX TUBE

ABSTRACT The results of an experimental investigation of the energy separation performance of a micro-scale Ranque-Hilsch vortex tube are presented in this paper. The micro-scale vortex tube is 2 mm in diameter and constructed using a layered technique from multiple pieces of Plexiglas and aluminum. Four inlet slots, symmetrically located around the tube, form the vortex. The hydraulic diameter of each inlet slot and the orifice diameter for the cold exit are 229 and 800 microns respectively. The working fluid is low pressure, nondehumidified compressed air at room temperature. The rate of the hot gas flow is varied by means of a control valve to achieve different values of cold mass fraction. The mass flow rates, temperatures and pressures of the supply and outlet flows are measured and the performance of the device presented. The supply channel Reynolds number is varied over a considerable range which extends into the laminar regime in order to determine the operating conditions for cooling. An increase in dimensionless temperature is found in both the cold and hot outlets as supply nozzle Reynolds number increases from zero. Maximum values occur at a Reynolds number of approximately 500 and the cold flow dimensionless temperature becomes negative at about 2500. Although the optimum cold mass ratio is higher than the conventional tubes, the effect on performance of tube length and cold exit diameter is similar to the conventional devices

Statistical Fluctuations of Electromagnetic Transition Intensities in pf-Shell Nuclei

We study the fluctuation properties of E2 and M1 transition intensities among T=0,1 states of A = 60 nuclei in the framework of the interacting shell model, using a realistic effective interaction for pf-shell nuclei with a Ni56 as a core. It is found that the B(E2) distributions are well described by the Gaussian orthogonal ensemble of random matrices (Porter-Thomas distribution) independently of the isobaric quantum number T_z. However, the statistics of the B(M1) transitions is sensitive to T_z: T_z=1 nuclei exhibit a Porter-Thomas distribution, while a significant deviation from the GOE statistics is observed for self-conjugate nuclei (T_z=0).Comment: 8 pages, latex, 3 figures (ps format

Disulfonated tetraphenyl chlorin (TPCS2a)–induced photochemical internalisation of bleomycin in patients with solid malignancies: A first-in-man phase I dose escalation clinical trial

BACKGROUND: Photochemical internalisation, a novel minimally invasive treatment, has shown promising preclinical results in enhancing and site-directing the effect of anticancer drugs by illumination, which initiates localised chemotherapy release. We assessed the safety and tolerability of a newly developed photosensitiser, disulfonated tetraphenyl chlorin (TPCS2a), in mediating photochemical internalisation of bleomycin in patients with advanced and recurrent solid malignancies. METHODS: In this phase 1, dose-escalation, first-in-man trial, we recruited patients (aged ≥18 to <85 years) with local recurrent, advanced, or metastatic cutaneous or subcutaneous malignancies who were clinically assessed as eligible for bleomycin chemotherapy from a single centre in the UK. Patients were given TPCS2a on day 0 by slow intravenous injection, followed by a fixed dose of 15 000 IU/m2 bleomycin by intravenous infusion on day 4. After 3 h, the surface of the target tumour was illuminated with 652 nm laser light (fixed at 60 J/cm2). The TPCS2a starting dose was 0·25 mg/kg and was then escalated in successive dose cohorts of three patients (0·5, 1·0, and 1·5 mg/kg). The primary endpoints were safety and tolerability of TPCS2a; other co-primary endpoints were dose-limiting toxicity and maximum tolerated dose. The primary analysis was per protocol. This study is registered with ClinicalTrials.gov, number NCT00993512, and has been completed. FINDINGS: Between Oct 3, 2009, and Jan 14, 2014, we recruited 22 patients into the trial. 12 patients completed the 3-month follow-up period. Adverse events related to photochemical internalisation were either local, resulting from the local inflammatory process, or systemic, mostly as a result of the skin-photosensitising effect of TPCS2a. The most common grade 3 or worse adverse events were unexpected higher transient pain response (grade 3) localised to the treatment site recorded in nine patients, and respiratory failure (grade 4) noted in two patients. One dose-limiting toxicity was reported in the 1·0 mg/kg cohort (skin photosensitivity [grade 2]). Dose-limiting toxicities were reported in two of three patients at a TPCS2a dose of 1·5 mg/kg (skin photosensitivity [grade 3] and wound infection [grade 3]); thus, the maximum tolerated dose of TPCS2a was 1·0 mg/kg. Administration of TPCS2a was found to be safe and tolerable by all patients. No deaths related to photochemical internalisation treatment occurred. INTERPRETATION: TPCS2a-mediated photochemical internalisation of bleomycin is safe and tolerable. We identified TPCS2a 0·25 mg/kg as the recommended treatment dose for future trials. FUNDING: PCI Biotech

A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families

Colorectal cancer (CRC) has a very high incidence in the western world. Data from registries in the Middle East showed that the incidence of CRC is relatively low in these countries. However, these data also showed that CRC incidence has increased substantially over the past three decades and that a high proportion of cases are diagnosed at an early age (<50 years). In view of these findings, more attention should be paid to prevention. Because of the often limited financial resources, focused screening of individuals with hereditary CRC, in particular those with Lynch syndrome, appears to be the most cost-effective strategy. During recent meetings of the Palestinian Society of Gastroenterology and the Mediterranean Task force for Cancer Control (MTCC) in Jericho, and the Patient�s Friends Society of Jerusalem in Hebron the issue of hereditary CRC in the Middle East was discussed and the idea was conceived to establish a network on hereditary colorectal cancer (HCCN-ME) with the goal of improving care for high-risk groups in the Middle East and (Eastern) Mediterranean Countries. © 2017, The Author(s)

International Geomagnetic Reference Field: the eleventh generation

The eleventh generation of the International Geomagnetic Reference Field (IGRF) was adopted in December 2009 by the International Association of Geomagnetism and Aeronomy Working Group V-MOD. It updates the previous IGRF generation with a definitive main field model for epoch 2005.0, a main field model for epoch 2010.0, and a linear predictive secular variation model for 2010.0-2015.0. In this note the equations defining the IGRF model are provided along with the spherical harmonic coefficients for the eleventh generation. Maps of the magnetic declination, inclination and total intensity for epoch 2010.0 and their predicted rates of change for 2010.0-2015.0 are presented. The recent evolution of the South Atlantic Anomaly and magnetic pole positions are also examine

A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families

Colorectal cancer (CRC) has a very high incidence in the western world. Data from registries in the Middle East showed that the incidence of CRC is relatively low in these countries. However, these data also showed that CRC incidence has increased substantially over the past three decades and that a high proportion of cases are diagnosed at an early age (<50 years). In view of these findings, more attention should be paid to prevention. Because of the often limited financial resources, focused screening of individuals with hereditary CRC, in particular those with Lynch syndrome, appears to be the most cost-effective strategy. During recent meetings of the Palestinian Society of Gastroenterology and the Mediterranean Task force for Cancer Control (MTCC) in Jericho, and the Patient�s Friends Society of Jerusalem in Hebron the issue of hereditary CRC in the Middle East was discussed and the idea was conceived to establish a network on hereditary colorectal cancer (HCCN-ME) with the goal of improving care for high-risk groups in the Middle East and (Eastern) Mediterranean Countries. © 2017, The Author(s)